Latest Drug War News

GoodShop: You Shop...We Give!

Shop online at and a percentage of each purchase will be donated to our cause! More than 600 top stores are participating!

The Internet Our Website

 Representative Barney Frank,

Democrat, of Newton, MA: born in Bayonne, NJ, March 31, 1940; attended the public schools; graduated, Bayonne High School, 1957; B.A. Harvard College, 1962; graduate student in political science, 1962-66; teaching fellow in Government, Harvard College, 1963-66; J.D., Harvard University, 1977; admitted to the Massachusetts bar, 1979; executive assistant to Mayor Kevin White of Boston, 1968-71; administrative assistant to U.S. Congressman Michael F. Harrington, 1971-72; member, Massachusetts Legislature, 1973-80; elected to the 97th Congress, November 4, 1980; reelected each succeeding Congress. Barney Frank is now serving his eighth term in the United States House of Representatives. Congressman Frank lives with Herb Moses.

In Congress, Representative Frank is a member of the following committees:

  • Judiciary Committee and the Banking
  • Financial Services Committee.

Representative Frank serves on the following subcommittees:

  • Judiciary Subcommittee on the Constitution, where he is the senior Democratic member.
  • Judiciary Subcommittee on Immigration and Claims.
  • Banking Subcommittee on Housing and Economic Opportunity.
  • Banking Subcommittee on Domestic and International Monetary Policy.

On November 10, 1995, Rep Frank introduced H.R. 2618, a bill to provide for the therapeutic use of marihuana in situations involving life-threatening or sense-threatening illnesses and to provide adequate supplies of marihuana for such use.

The Bill had 18 cosponsors, but it died with the 104th Congress. Look for a similar Bill to be introduced in the 105th.

 Cosponsors of H.R. 2818
Rep Johnston - 11/10/95
Rep Pelosi - 11/10/95
Rep Studds - 11/16/95
Rep Beilenson - 11/17/95
Rep Dellums - 12/11/95
Rep Olver - 12/14/95
Rep Woolsey - 01/03/96
Rep Stark - 01/22/96
Rep Conyers - 02/13/96
Rep Gunderson - 02/27/96
Rep Kennedy, J. - 02/27/96
Rep Lofgren - 03/19/96
Rep Campbell - 03/19/96
Rep Bilbray - 03/27/96
Rep Sanders - 04/15/96
Rep Brown, G. - 04/15/96
Rep Slaughter - 05/07/96 (withdrawn - 06/18/96)
Rep Dixon - 06/27/96
Rep Farr - 09/09/96


HON. BARNEY FRANK, in the House of Representatives


Mr. FRANK of Massachusetts. Mr. Speaker, recently I introduced
legislation which would allow physicians to prescribe marijuana when in their judgment it is medically appropriate to do so. I first became a supporter of this legislation more than a decade ago, when it was introduced by our late colleague, the gentleman from Connecticut Mr. McKinney. I was recently advised of a resolution passed by The American Public Health Association which supports the concept embodied in the legislation I have introduced and I ask that this resolution be printed here.
The American Public Health Association:
Being aware that cannabis/marijuana has been used medicinally for centuries and that cannabis products were widely prescribed by physicians in the United States until 1937; and
Being aware that `marijuana' prohibition began with the Marijuana Tax Act of 1937 under false claims despite disagreeing testimony from the AMA's representative; and
Being further aware that the Controlled Substances Act of 1970 completely prohibited all medicinal use of marijuana by placing it in the most restrictive category of Schedule I, whereby drugs must meet three criteria for placement in this category: 1) have no therapeutic value, 2) are not safe for medical use, and 3) have a high abuse potential; and
Being cognizant that the Drug Enforcement Administration's own administrative law judge ruled in 1988 that marijuana must be removed from Schedule I and made available for physicians to prescribe; and
Knowing that 36 states have passed legislation recognizing marijuana's therapeutic value; and
Also knowing that the only available access to legal marijuana which was through the Food and Drug Administration's Investigational New Drug Program has been closed by the Secretary of Health and Human Services since 1991; and
Understanding that while synthetic Tetrahydrocannibinol (THC) is available in pill form, it is only one of approximately 60 cannabinoids which may have medicinal value individually or in some combination; and
Understanding that marijuana has an extremely wide acute margin of safety for use under medical supervision and cannot cause lethal reactions; and
Understanding that marijuana has been reported to be effective in: a) reducing intraocular pressure in glaucoma; b) reducing nausea and vomiting associated with chemotherapy; c) stimulating the appetite for patients living with AIDS (acquired immunodeficiency syndrome) and suffering from the wasting syndrome; d) controlling spasticity associated with spinal cord injury and multiple sclerosis; e) decreasing the suffering from chronic pain; and f) controlling seizures associated with seizure disorders; and
Understanding that marijuana seems to work differently than many conventional medications for the above problems, making it a possible option for persons resistant to the conventional medications; and
Being concerned that desperate patients and their families are choosing to break the law to obtain this medicine when conventional medicines or treatments have not been effective for them or are too toxic; and
Realizing that this places ill persons at risk for criminal charges and at risk for obtaining contaminated medicine because of the lack of quality control; and
Realizing that thousands of patients not helped by conventional medications and treatments, may find relief from their suffering with the use of marijuana if their primary care providers were able to prescribe this medicine; and
Concluding that cannabis/marijuana was wrongfully placed in Schedule I of the Controlled Substances depriving patients of its therapeutic potential.
Recognizing the APHA adopted a resolution (7014) on Marijuana and the Law which urged federal and state drugs laws to exclude marijuana from classification as a narcotic drug; and
Concluding that greater harm is caused by the legal consequences of its prohibition than possible risks of medicinal use; therefore
1. Encourages research of the therapeutic properties of various cannabinoids and combinations of cannabinoids; and
2. Encourages research on alternative methods of administration to decrease the harmful effects related to smoking; and
3. Urges the Administration and Congress to move expeditiously to make cannabis available as a legal medicine where shown to be safe and effective and to immediately allow access to therapeutic cannibis through the Investigational New Drug Program.

Working to end drug war injustice

Meet the People Behind The U.S. Sentencing Guidelines

Questions or problems? Contact